统一多发性硬化中独立于复发活动的进展定义
该研究基于意大利多发性硬化登记库30,203例复发型多发性硬化患者,评估了18种PIRA定义对长期残疾(EDSS=6.0)的预测性能。结果显示采用浮动基线、事件前90天及事件后30天无复发、24周确认的定义具有最佳预测价值与可行性,支持其用于常规临床与研究。
要点
- PIRA是复发型多发性硬化残疾累积的主要驱动因素。
- 18种PIRA定义中,事件前后无复发时间窗影响敏感性与特异性。
- 浮动基线+90天前/30天后无复发+24周确认的定义预测价值最佳。
核心结论
- 结合浮动基线、事件前90天及事件后30天无复发、24周确认的PIRA定义预测长期残疾价值最佳且可行。
研究设计与样本
- 从意大利多发性硬化及相关疾病登记库提取2000年1月1日后首次就诊、至少3次EDSS评估且随访≥5年的复发型多发性硬化患者。
- 共纳入30,203例患者,平均随访11.3±4.3年,评估18种PIRA定义对EDSS=6.0的预测性能。
主要发现
- 随访期间PIRA发生率为38.8%至74.1%,4,401例(15%)患者达到EDSS=6.0。
- 采用90天标准(事件前≤90天及事件后≤30天无复发)的PIRA定义敏感性较高(66.7%-69.4%)。
- 采用ABS标准(基线至确认评分期间无复发)的PIRA定义特异性较高(55.3%-62.2%)。
关键数值与推荐
- PIRA定义组合包括固定或浮动基线、24周或48周确认或持续残疾累积、以及三种无复发时间窗标准。
- 最佳预测价值的定义为:浮动基线、事件前90天及事件后30天无复发、24周确认。
临床怎么用
- 推荐在常规临床实践和研究中采用浮动基线、事件前90天及事件后30天无复发、24周确认的PIRA定义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Progression independent of relapse activity (PIRA) is the main driver of disability accumulation in relapsing multiple sclerosis (MS). We tested various PIRA definitions against the risk of long-term disability. METHODS: Patients with relapsing MS, first visit ≥January 1, 2000, ≥3 visits with Expanded Disability Status Scale (EDSS), and ≥5-year follow-up were extracted from the Italian MS and Related Disorders Register on September 29, 2023. Eighteen PIRA definitions were obtained combining fixed or roving baseline, 24-week, 48-week confirmed or sustained disability accrual, no relapses ≤90 days before/≤30 days after the event (90d), ≤180 days before/≤30 days after the event, or absence of relapses from baseline to confirmation score (ABS). Predictive performance against the reaching of EDSS = 6.0 was calculated. RESULTS: A total of 30,203 patients were included. After a follow-up of 11.3 ± 4.3 years, PIRA ranged from 38.8% to 74.1%. EDSS = 6.0 was detected in 4,401 (15%) patients. Sensitivity of PIRA definitions against EDSS = 6.0 was higher using the 90d criterion (66.7%-69.4%), while the ABS criterion increased specificity (55.3%-62.2%). DISCUSSION: The definition of PIRA combining roving baseline, no relapses 90 days before and 30 days after the event and 24-week confirmation achieved the best predictive value and feasibility, supporting its use in routine practice and research.
引用
- Portaccio E, Betti M, De Meo E, et al. Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple Sclerosis. Neurology. 2025. PMID: 40982769. doi:10.1212/WNL.0000000000213977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。